Wikidata

(Q64639217)

English

To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)

clinical trial

In more languages

Statements

title
A Randomized, Double-blind, Parallel, Placebo-controlled Study Assessing the Efficacy and Safety of Sarilumab Added to Non-biologic DMARD Therapy in Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF-α Antagonists (English)
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Brazil
0 references
Canada
0 references
Chile
0 references
Colombia
0 references
Ecuador
0 references
Germany
0 references
Greece
0 references
Guatemala
0 references
Hungary
0 references
Israel
0 references
Italy
0 references
Lithuania
0 references
Mexico
0 references
New Zealand
0 references
Peru
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Slovakia
0 references
Spain
0 references
Taiwan
0 references
Turkey
0 references
Ukraine
0 references
start time
October 2012
0 references
end time
March 2015
0 references
number of participants
546
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64639217&oldid=1857827157"